Why This Biotech Fund Increased Its Oruka Stake Amid a 500% Rally
A biotech fund just boosted its Oruka Therapeutics position after a blistering rally. Here’s what the move signals ab...
Searching for credit cards with high reward points? Explore our selection to maximize your earning potential on everyday spending.
27,958 articlesA biotech fund just boosted its Oruka Therapeutics position after a blistering rally. Here’s what the move signals ab...
A surge in AI and software stocks is driving big, daily swings in CEO wealth even as pay packages grow. Investors oft...
Bittensor's TAO aims to blend AI training services with blockchain incentives. After a sharp rally, investors wonder ...
IBM faces a tougher 2026 as AI and cloud shifts hit margins. With a sharp price drop and a sizable upside versus cons...
When big names place bets, markets listen. This piece breaks down what cathie wood buying cerebras could mean for you...
KBR faced a two-sided story: a massive backlog that hints at strong future demand, and a prominent investor trimming ...
Lululemon faces a pivotal moment after its latest earnings. This analysis breaks down what's working, what's slowing,...
A five-month run lifted Taiwan’s ETF well ahead of the S&P 500, turning a $10,000 stake into $16,178 as semiconductor...
A 25 percent drop often triggers fear and temptation to buy the dip. This article breaks down IBM s recent results, t...
ServiceNow stands near $112 ahead of July 22 earnings, with a bullish setup built on rising subscription growth, soli...
Redwire Corporation stock popped today as investors weighed contract news, analyst commentary, and growth potential. ...
The nuclear energy story 2026 is taking shape as decarbonization and power-hungry data demand push expansion. This gu...